Secondary erythermalgia in an HIV-1-positive patient

AIDS Reader

Volumn 13, Issue 2, 2003, Pages 91-93

  Dolan, Christopher K ^a   Hall, Mark A ^b   Turiansky, George W ^c  

^a Patuxent River Naval Medical Clinic   (United States)

^b Natl Cap Consortium Dermatol R   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Aspirin; Erythromelalgia; HIV AIDS; Secondary erythermalgia

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BUPIVACAINE; COTRIMOXAZOLE; DILTIAZEM; DOXEPIN; EFAVIRENZ; FLUCONAZOLE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; INDINAVIR; LAMIVUDINE; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PREDNISONE; PROSTAGLANDIN;

ARTICLE; CLINICAL FEATURE; DERMATOLOGY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ERYTHROMELALGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ID REACTION; PARONYCHIA; PATHOGENESIS;

ADULT; ERYTHROMELALGIA; HIV INFECTIONS; HIV-1; HUMANS; MALE;

EID: 0037308157     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol. 2000;43:841-847.
2. Davis MD, O'Fallon M, Rogers RS, et al. Natural history of erythromelalgia. Arch Dermatol. 2000;136: 330-336.
3. Itin PH, Courvoisier S, Stoll A, et al. Secondary erythermalgia in an HIV-infected patient: is there a pathogenetic relationship? Acta Derm Venereol. 1996; 76:332-333.
4. Mork C, Kalgaard OM, Myrvang B, Kvernebo K. Erythromelalgia in a patient with AIDS. J Eur Acad Dermatol Venereol. 2000;14:498-500.
5. Thompson GH, Hahn G, Rang M. Erythromelalgia. Clin Orthop. 1979;144:249-254.
6. Mork C, Kvernebo K. Erythromelalgia - a mysterious condition? Arch Dermatol. 2000;136:406-409.
7. Michiels JJ, Drenth JP, Van Genderen PJ. Classification and diagnosis of erythromelalgia and erythermalgia. Int J Dermatol. 1995;34:97-100.
8. Yosipovitch G, Krause I, Blickstein D. Erythromelalgia in a patient with thrombotic thrombocytopenic purpura. J Am Acad Dermatol. 1992;26:825-827.
9. Alam M, Scher RK. Indinavir related recurrent paronychia and ingrown toenails. Cutis. 1999;64:277-278.
10. Colson AE, Sax PE, Keller MJ, et al. Paronychia in association with indinavir treatment. Clin Infect Dis. 2001;32:140-143.
11. Tosti A, Piraccini BM, D'Antonio A, et al. Paronychia associated with antiretroviral treatment. Br J Dermatol. 1999;140:1165-1168.
12. Davis MD, Rooke TW, Sandroni P. Mechanisms other than shunting are likely contributing to the pathophysiology of erythromelalgia. J Invest Dermatol. 2000;115:1166-1167.
13. Mork C, Asker CL, Salerud EG, et al. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol. 2000;114:643-646.
14. Drenth JP, Michiels JJ, van Joost T, Vuzevski VD. Secondary erythermalgia associated with an auto-immune disorder of undetermined significance. Dermatology. 1995;190:232-234.
15. Pechere M, Krischer J, Trellu L, et al. Persistent periungual erythema with telangiectasia: red fingers syndrome. Arch Dermatol. 1999;135:715-716.
16. Guyton A, Hall J. Textbook of Medical Physiology. Philadelphia: WB Saunders Co; 1996:597.
17. Sandroni P, Davis MD, Harper CM Jr, et al. Neurophysiologic and vascular studies in erythromelalgia: retrospective analysis. J Clin Neuromuscular Dis. 1999;1:57-63.
18. Stricker LJ, Green CR. Resolution of refractory symptoms of secondary erythermalgia with intermittent epidural bupivacaine. Reg Anesth Pain Med. 2001;26:488-490.